{"transactions":[{"id":863921,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-03-04T21:35:45.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":735000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Issuer's Board of Directors on January 26, 2026, with a grant date of March 2, 2026 (the \"Grant Date\"), and represents the Reporting Person's annual equity award for 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests and becomes exercisable over four years in 48 substantially equal monthly installments beginning on the date that is one month after the Grant Date, subject to the Reporting Person's continued service on each vesting date."}],"balance_after":735000,"derivative":{"exercise_price":5.35,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":735000},"source":{"system":"sec-edgar","filing":"0001535289-26-000003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000153528926000003/ownership.xml","form_type":"4"}},{"id":1187400,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-01T22:44:41.000Z","date":"2025-03-28","kind":"purchase","planned":false,"acquired":true,"shares":4650,"price":2.2125,"value":10288.125,"ownership":{"direct":false,"nature":"By Child #1"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.1900 to $2.2450, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price in the transaction described in this footnote."}],"balance_after":4650,"source":{"system":"sec-edgar","filing":"0000950170-25-048775","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017025048775/ownership.xml","form_type":"4"}},{"id":1187399,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-01T22:44:41.000Z","date":"2025-03-28","kind":"purchase","planned":false,"acquired":true,"shares":22026,"price":2.2421,"value":49384.4946,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.1900 to $2.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares purchased at each separate price in the transaction described in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Previous Form 4s filed on behalf of the Reporting Person under-reported the Reporting Person's holdings by 1,100 shares of Common Stock. The amount reported in this Form 4 reflects the correct amount."}],"balance_after":59383,"source":{"system":"sec-edgar","filing":"0000950170-25-048775","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017025048775/ownership.xml","form_type":"4"}},{"id":1224989,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-03-05T21:27:38.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Issuer's Board of Directors on February 12, 2025, with a grant date of March 3, 2025 (the \"Grant Date\"), and represents the Reporting Person's annual equity award for 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests and becomes exercisable over four years in 48 substantially equal monthly installments beginning on the date that is one month after the Grant Date, subject to the Reporting Person's continued service on each vesting date."}],"balance_after":650000,"derivative":{"exercise_price":2.46,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0000950170-25-033662","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017025033662/ownership.xml","form_type":"4"}},{"id":1343958,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-12-04T22:20:03.000Z","date":"2024-12-04","kind":"purchase","planned":false,"acquired":true,"shares":8000,"price":3.7665,"value":30132.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7596 to $3.7700, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transactions described in this footnote."}],"balance_after":36257,"source":{"system":"sec-edgar","filing":"0000950170-24-133355","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024133355/ownership.xml","form_type":"4"}},{"id":1352165,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-11-26T12:00:04.000Z","date":"2024-11-25","kind":"purchase","planned":false,"acquired":true,"shares":6600,"price":3.8,"value":25080.0,"ownership":{"direct":false,"nature":"By IRA of Spouse"},"balance_after":66600,"source":{"system":"sec-edgar","filing":"0000950170-24-130754","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024130754/ownership.xml","form_type":"4"}},{"id":1352164,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-11-26T12:00:04.000Z","date":"2024-11-25","kind":"purchase","planned":false,"acquired":true,"shares":5400,"price":3.8,"value":20520.0,"ownership":{"direct":false,"nature":"By IRA of Reporting Owner"},"balance_after":5400,"source":{"system":"sec-edgar","filing":"0000950170-24-130754","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024130754/ownership.xml","form_type":"4"}},{"id":1352163,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-11-26T12:00:04.000Z","date":"2024-11-25","kind":"purchase","planned":false,"acquired":true,"shares":14500,"price":3.784,"value":54868.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.645 to $3.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transactions described in this footnote."}],"balance_after":152072,"source":{"system":"sec-edgar","filing":"0000950170-24-130754","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024130754/ownership.xml","form_type":"4"}},{"id":1471496,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock option (right to buy)","published_at":"2024-06-24T20:09:03.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests over four years with 1/48th of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the monthly anniversary after the Grant Date (06/20/2024), subject to a continued service relationship."}],"balance_after":500000,"derivative":{"exercise_price":10.65,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000950170-24-076716","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024076716/ownership.xml","form_type":"4"}},{"id":1481522,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-06-13T21:19:02.000Z","date":"2024-06-13","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":1.1743,"value":117430.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is a weighted average price. The prices actually paid ranged from $1.1650 to $1.1800. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or a securityholder of the issuer, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":137572,"source":{"system":"sec-edgar","filing":"0000950170-24-073145","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024073145/ownership.xml","form_type":"4"}},{"id":1711787,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Options (right to buy)","published_at":"2023-12-14T23:42:51.000Z","date":"2023-12-12","kind":"grant","planned":false,"acquired":true,"shares":3338878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 12/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 12/12/2024, until fully vested."}],"balance_after":11793635,"derivative":{"exercise_price":0.24,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":3338878},"source":{"system":"sec-edgar","filing":"0001437749-23-034479","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923034479/rdgdoc.xml","form_type":"4"}},{"id":3180653,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2020-04-07T23:46:50.000Z","date":"2020-04-06","kind":"grant","acquired":true,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Options issued in connection with the Reporting Person's service on the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options vest immediately, with the remainder vesting in equal installments on each of June 30, 2020, September 30, 2020 and December 31, 2020."}],"balance_after":80000,"derivative":{"exercise_price":0.97,"expiration_date":"2030-04-06","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001415889-20-000964","document":"form4-04072020_040436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000141588920000964/form4-04072020_040436.xml","form_type":"4"}},{"id":3713329,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2019-01-02T23:47:53.000Z","date":"2018-12-28","kind":"purchase","acquired":true,"shares":38583,"price":1.2951,"value":49968.8433,"ownership":{"direct":true},"balance_after":338617,"source":{"system":"sec-edgar","filing":"0001415889-19-000017","document":"form4-01022019_030137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000141588919000017/form4-01022019_030137.xml","form_type":"4"}},{"id":3867290,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2018-07-17T01:08:33.000Z","date":"2018-07-12","kind":"grant","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents grant of restricted stock. Shares shall vest in increments as follows: (i) 1/6 upon the acceptance of a U.S. IND for MS 1819; (ii) 1/6 upon the the first CF patient dosed with MS1819 anywhere in the globe; (iii) 1/6 upon upon enrollment of the first 30 patients in a CF trial; (iv) 1/6 on July 12, 2019; (v) 1/6 on July 12, 2020; and (vi) 1/6 on July 12, 2021."}],"balance_after":300034,"source":{"system":"sec-edgar","filing":"0001415889-18-001121","document":"form4-07162018_060717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000141588918001121/form4-07162018_060717.xml","form_type":"4"}},{"id":4163698,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Options","published_at":"2017-11-14T23:20:18.000Z","date":"2017-11-10","kind":"other","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents options granted to the Reporting Person by third parties."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":200000,"derivative":{"exercise_price":1,"expiration_date":"2021-01-04","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-17-001785","document":"form4-11142017_031107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000141588917001785/form4-11142017_031107.xml","form_type":"4"}},{"id":4163697,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2017-11-14T23:20:18.000Z","date":"2017-11-10","kind":"other","acquired":true,"shares":100000,"price":1,"value":100000.0,"ownership":{"direct":true},"balance_after":100034,"source":{"system":"sec-edgar","filing":"0001415889-17-001785","document":"form4-11142017_031107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000141588917001785/form4-11142017_031107.xml","form_type":"4"}},{"id":4464205,"issuer":{"id":7534,"kind":"organization","name":"GridAI Technologies Corp.","symbol":"GRDX"},"owners":[{"id":63027,"kind":"person","name":"Spoor Johan M.","position":1,"cik":"0001535289","reported_name":"Spoor Johan M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Options","published_at":"2017-02-07T21:36:38.000Z","date":"2017-02-03","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":100000,"derivative":{"exercise_price":4.48,"exercise_date":"2017-02-03","expiration_date":"2027-02-03","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-17-000210","document":"form4-02072017_010228.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604191/000141588917000210/form4-02072017_010228.xml","form_type":"4"}}]}